Literature DB >> 23541439

Increased intra-abdominal fat predicts perioperative complications following minimally invasive partial nephrectomy.

Michael A Gorin1, Jeffrey K Mullins, Phillip M Pierorazio, Gautam Jayram, Mohamad E Allaf.   

Abstract

OBJECTIVE: To evaluate the anthropometric measurements of body mass index, outer-abdominal fat (OAF) and intra-abdominal fat (IAF) for their utility in predicting perioperative complications following minimally invasive partial nephrectomy.
METHODS: We retrospectively reviewed the clinical data of patients who underwent a laparoscopic or robotic partial nephrectomy between August 2006 and July 2012 by a single surgeon. Measurements of OAF and IAF were obtained from preoperative cross-sectional imaging available through our institution's imaging archive. Preoperative clinical parameters, including BMI, OAF and IAF, were evaluated for associations with postoperative complications, operative time and length of hospital stay.
RESULTS: In total, 257 patients underwent a minimally invasive partial nephrectomy during the study period. Of these patients, 195 (75.9%) had preoperative scans available for analysis of OAF and IAF. A total of 52 (26.7%) patients experienced a Clavien grade I-IV complication within 30 days of surgery, 18 (34.6%) of which were grade III-IV. No patient experienced a grade V complication. On multivariate analysis, only increasing IAF (OR 1.05 [95% CI 1.02-1.09], P = .005) was associated with grade I-IV complications, while IAF (OR 1.05 [95% CI 1.00-1.10], P = .04) and intermediate to high tumor complexity (OR 5.31 [95% CI 1.47-19.17], P = .01) were associated with grade III-IV complications. BMI, OAF and IAF were not found to be independently associated with operative time or length of hospital stay.
CONCLUSION: IAF is independently associated with complications following minimally invasive partial nephrectomy. With further validation, this measurement may prove useful in the preoperative risk stratification of patients with small renal masses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541439     DOI: 10.1016/j.urology.2012.12.053

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  An increasing proportion of perinephric to subcutaneous fat is associated with adverse perioperative outcomes of robotic partial nephrectomy.

Authors:  Jay D Raman; Christopher Reynolds; Michael Hannon
Journal:  J Robot Surg       Date:  2016-05-09

Review 2.  Nephron-sparing surgery.

Authors:  Paul Maroni; Jacob Moss
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

3.  The impact of body mass index on renal functional outcomes following minimally invasive partial nephrectomy.

Authors:  Kyle A Richards; Edris Negron; Joshua A Cohn; Zoe Steinberg; Scott E Eggener; Arieh L Shalhav
Journal:  J Endourol       Date:  2014-08-21       Impact factor: 2.942

Review 4.  Perioperative complications of robot-assisted partial nephrectomy.

Authors:  Eric H Kim; Jeffrey A Larson; Michael Figenshau; R Sherburne Figenshau
Journal:  Curr Urol Rep       Date:  2014-01       Impact factor: 3.092

5.  Visceral fat is associated with high-grade complications in patients undergoing minimally invasive partial nephrectomy for small renal masses.

Authors:  Kelan Nesbitt; Pranav Sharma
Journal:  Curr Urol       Date:  2021-03-29

6.  Study on the correlation between preoperative inflammatory indexes and adhesional perinephric fat before laparoscopic partial nephrectomy.

Authors:  Teng Ma; Lin Cong; Qianli Ma; Zhaoqin Huang; Qianqian Hua; Xiaojiao Li; Ximing Wang; Yunchao Chen
Journal:  BMC Urol       Date:  2021-12-10       Impact factor: 2.264

7.  Significant impact of three-dimensional volumetry of perinephric fat on the console time during robot-assisted partial nephrectomy.

Authors:  Daisuke Motoyama; Yuto Matsushita; Hiromitsu Watanabe; Keita Tamura; Toshiki Ito; Takayuki Sugiyama; Atsushi Otsuka; Hideaki Miyake
Journal:  BMC Urol       Date:  2019-12-12       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.